| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |